MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients
Wataru Sugimoto1, Katsuhiko Itoh1, Hiroaki Hirata2
1Frontiers of Innovative Research in Science and Technology, Konan University, Kobe 650-0047, Japan.
Extracellular matrix (ECM) stiffening activates Yes-associated protein (YAP), inducing matrix metalloproteinase (MMP)-24 expression. Lower MMP24 levels correlate with worse breast cancer survival, suggesting MMP24 inhibits tumor aggressiveness.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Tumor progression involves extracellular matrix (ECM) stiffening, impacting cancer cell invasion and proliferation.
- Yes-associated protein (YAP) acts as a mechanotransducer, influencing gene expression in response to mechanical cues.
Purpose of the Study:
- To investigate matrix metalloproteinase (MMP)-24 as a novel target gene of YAP.
- To elucidate the role of ECM stiffness in regulating MMP24 expression via YAP.
Main Methods:
- Culturing MCF-7 breast cancer cells on substrates of varying stiffness.
- Analyzing MMP24 expression levels following YAP knockdown and with constitutively active YAP.
- Performing chromatin immunoprecipitation (ChIP) assays to confirm YAP binding to the MMP24 promoter.
Main Results:
- MMP24 expression was significantly upregulated on stiff substrates compared to soft substrates.
- YAP knockdown reduced MMP24 expression, while active YAP increased MMP24 promoter activity.
- YAP was confirmed to bind directly to the MMP24 promoter.
Conclusions:
- ECM stiffening activates YAP, leading to increased MMP24 expression.
- MMP24 may function as a tumor suppressor by negatively regulating cancer cell aggressiveness in stiff ECM environments.
- Lower MMP24 expression in breast cancer patients is associated with poorer survival rates.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
